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Abstract
Background and aims Reducing health care costs through
preventive geriatric care has become a high priority in
Japan. We analyzed data from a randomized controlled
trial to examine the effects of a preventive home visit
program on health care costs among ambulatory frail
elders.
Methods Structured preventive home visits by nurses or
care managers were provided to the visit group every
6 months over 2 years. The enrolled participants
(N = 323) were randomly assigned to either the visit group
(N = 161) or the control group (N = 162). We analyzed
the health care costs, including the costs for hospitaliza-
tions and outpatient clinic utilization for participants who
had health care insurance from the local government
(N = 307). The visit group included 154 individuals in the
visit group and 153 people in the control group.
Results Total health care costs over the study period were
not significantly different between groups, but at most
monthly time points costs and those for outpatient clinic
utilization in the visit group were lower than those in the
control group. Hospitalizations, which accounted for more
than ¥500,000 JPY per month, were less likely to occur
more often among participants in the visit group (N = 71)
than in the control group (N = 113) (OR = 0.63;
p = 0.002).
Conclusions These results suggest that a preventive home
visit program may reduce monthly health care costs, pri-
marily by reducing hospitalization costs.
Keywords Frail elderly  Health care costs 
Hospitalization  Home visits  Randomized
controlled trial
Introduction
Several studies have recently documented the effects of
preventive home visit programs for community-dwelling
older individuals [1–5]. Particularly favorable outcomes
have been associated with certain population subgroups
based on multidimensional assessments and multiple fol-
low-up home visits [6–8].
The positive effects of preventive home visits have been
documented with regard to functional and psychosocial
parameters and health care utilization. However, the results
have been inconsistent. Some studies have not conclusively
found that home visit programs are cost-effective [9, 10].
Other studies have demonstrated the cost effectiveness of
home visit programs in terms of a reduction in the utili-
zation of emergency health services among elderly indi-
viduals [11–13] or a delay in their first emergency
admission to a hospital [13]. A randomized controlled trial
(RCT) suggested that the hospital and institutional costs for
subjects receiving home visits were less than those for
subjects who were not receiving home visits; however,
among subjects receiving home visits, the home care, adult
day care, and meals-on-wheels costs were increased, which
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offset much of the savings [14]. Most of these trials were
conducted in European countries [9, 10, 12–14] or the
United States [11], and the results have varied across
national settings and systems.
Thus, there is no simple answer regarding the effects of
home visits or their cost-effectiveness [6], and more evidence
is required in various countries and health care settings.
Japan provides a particularly fertile ground for such
studies. First, Japan has become the most aged society
worldwide, with a low birth rate and high longevity, and
the proportion of elderly individuals aged 65 years or older
in the population reached 23.1 % in 2010 and is projected
to reach 40.5 % in 2055 [15].
Second, since 2000, the Japanese government has
operated a unique system of mandatory public long-term
care insurance (LTCI) that is based on social insurance
principles that mandate benefits regardless of income or
family situation [16]. Formal facility-based care (including
nursing homes, group homes, and respite care) and com-
munity-based care (including adult day care, home aid,
home modifications, and partial visiting nursing care) are
reimbursed by the LTCI program.
Finally, Japan provides universal health coverage
through employee-based or community-based social health
insurance programs [17]. In 2010, the proportion of indi-
viduals aged 60 years or older who utilized health care
services more than once per week was 61.6 %. This pro-
portion is higher than those reported in other countries,
such as the United States (24.6 %), Germany (32.9 %), and
Sweden (14.6 %) [15].
Japan faces a challenge inherent in social health insur-
ance [17] or LTCI. Although improving health care by
preventing geriatric syndromes and elderly functional
decline has been one of the highest priorities, the increas-
ingly aging society ultimately raises the cost of care. In the
past decade, several RCTs [18–20] have examined the
effects of preventive home visit programs for frail elderly
Japanese people, but these studies have not presented
outcomes related to health care costs.
Based on our multidimensional assessment model of
preventive home visits [21], we previously reported a RCT
that demonstrated that these home visits were effective for
improving the functional status and depression among
ambulatory frail elderly people with dependency in activ-
ities of daily living (ADLs) [22]. We hypothesized that the
preventive home visit program may also be able to reduce
health care costs, which is the subject of the present
analysis [22]. The aim of this study was to examine the
effects of a preventive home visit program on health care
costs for hospitalizations and outpatient clinic utilization in




A single-blind randomized controlled trial was performed
in 3 suburban municipalities in Osaka, Japan, and the
subjects were followed for 2 years. Details on the proce-
dures and selection of the study participants have been
previously published [21, 22].
The purpose of the study and the process of analyzing
the health care cost data from local government documents
were explained to the study participants. The present study
protocol was approved by the Nursing Research Ethical
Committee of Osaka City University (No. 19-3-3, October
01, 2007) and was registered at the UMIN clinical trials
registry approved by ICMJE (No. UMIN000001113, April
07, 2008).
Participants
Operational definition of ambulatory frail elders was as
being classified into the two lowest care need levels in the
LTCI system: Support Levels 1 and 2 (out of 7). The
participants were identified from the list of LTCI-certified
residents that is maintained at each local government
office. The eligibility criteria included the following: (1)
age of 65 years or older, (2) certified as Support Level 1 or
2 in the LTCI system, (3) living at home at the time of the
baseline survey, and (4) not having utilized formal long-
term care services that are reimbursed by the LTCI system
in the previous 3 months. We focused on eligible subjects
without recent utilization to examine the effects of the
program on this unique subgroup and the ability of the
program to prevent the utilization of long-term care ser-
vices [22].
There were 1,764 elders who were certified as Support
Level 1 or 2 at the end of September (1 municipality) and
November (2 municipalities) of 2007. Of these individuals,
568 were eligible (i.e., not using long-term care services) to
participate in the baseline survey, which was conducted
between December 2007 and February 2008. After the
baseline survey, 323 participants remained eligible and
were willing to be randomly assigned to either the visit
group (N = 161) or the usual care group (N = 162) by
researchers using computer-generated random numbers
stratified by sex, age group, and district within each
community.
The characteristics of the original study participants at
baseline are shown in Table 1: their mean age was
80 years, 74 % were females, and their mean ADL scores
measured on the Barthel Index [23] were approximately 90
out of 100.
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The types of health insurance used by the participants
are also shown in Table 1: ‘‘Prefecture-level health insur-
ance’’ covers elderly individuals aged 75 years or older,
and ‘‘municipality-level (city or town-level) health insur-
ance’’ covers individuals aged 74 years or younger. Typi-
cally, Japanese individuals have community-based health
insurance after retirement, although some individuals
continue to have health insurance from their former
employers even after retirement. Individuals who receive
public assistance are not enrolled in any social health
insurance, and can receive health care without charge in
any hospital or clinic [17].
A total of 307 participants in the present analysis were
elderly individuals who had community-based health
insurance (at the prefecture or municipality level), with 154
people in the visit group (mean age 80.5 ± 6.3 years;
72.7 % female) and 153 people in the control group (mean
age 79.9 ± 6.6 years; 73.9 % females).
Data collection
The monthly health care costs for all types of hospitaliza-
tion, including acute care, mental health care, tuberculosis
care, and rehabilitation care, as well as outpatient clinic
utilization were included in the analysis. Over the 2-year
study period, records from both prefecture- and munici-
pality-level health insurance plans were collected from
local government offices.
Preventive home visits
For elders in the visit group, routine preventive home visits
were conducted every 6 months for 2 years by community
health nurses or care managers who were affiliated with
municipal community-based comprehensive care centers
(according to the LTCI reform plan of 2005). The visits
included structured multidimensional interview-based
assessments of five key elements: locomotion, daily
activities, social contacts or relationships with other peo-
ple, health conditions, and signs of abuse [21]. Home vis-
itors documented 40 potential health or psychosocial
problems or difficulties and provided recommendations to
each individual elder or caregiver [21]. All four visits were
completed for the majority of participants (1st visit 87 %,
2nd visit 85.7 %, 3rd visit 83.9 %, and 4th visit 83.9 %).
Further information can be found in our previous articles
[21, 22]. We paid ¥5,000 JPY (approximately $50 USD)
per person per year for the present preventive home visits
from our research grant to municipal community-based
comprehensive care centers.
Statistical analysis
All analyses were conducted on an intention-to-treat basis
(including cases in which participants refused the inter-
vention after the randomization). The software program
SAS version 9.2 was used, and a 2-tailed probability level
of less than 0.05 indicated statistical significance. At the
time of the 2-year follow-up, 11 individuals in the visit
group and 20 individuals in the control group had died, and
5 individuals in the visit group and 3 individuals in the
control group had been institutionalized. We included the
data from the participants who had died, had been admitted
to the hospital, or had been institutionalized during the
study period. However, data from participants who had
moved out of the study area (six individuals in the visit
group and six individuals in the control group) were not
included, as follow-ups were not possible.
Because the kurtosis and skewness of the health care
cost values were high, the log-transformed values of the
total or monthly health care costs and health care costs for
outpatient clinic utilization were evaluated using a t test.
Every month during the study period the number of
participants who were hospitalized ranged from 5 to 15,
and the individual raw data of the monthly hospital health
care costs were plotted to compare the distribution between
the groups. The monthly hospital care refers to the con-
tinuous cost for hospitalization within a month, and we did
not count the number of hospitalizations or hospitals. For
example, for a person hospitalized from January 1 to
February 10 at a hospital, we counted the costs from Jan-
uary 1 to January 31 and from February 1 to February 10







Age 80.3 (6.7) 79.6 (6.4)
Female, N (%) 119 (73.9) 120 (74.1)
Support Level 1 (lowest LTCI
certification level), N (%)
76 (47.2) 79 (48.8)
Living alone, N (%) 43 (26.7) 47 (29.0)
ADLsa, Mean (SD) 90.2 (11.7) 91.4 (12.2)
Type of health care insurance
Prefecture-level health insurance of
elders aged at least 74 years, N (%)
130 (80.8) 127 (78.4)
Municipality-level health insurance,
N (%)
24 (14.9) 26 (16.0)
Employee-based health insurance,
N (%)
4 (2.5) 5 (3.1)
Public assistance, N (%) 3 (1.9) 4 (2.5)
a ADLs were measured using the Barthel Index. The scores ranged
from 0, which represents an unfavorable ADL, to 100, which repre-
sents a favorable ADL
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separately to provide the costs of January and February,
respectively. The difference in the number of hospitaliza-
tions that accounted for more than ¥500,000 JPY per month
per month was examined between the groups according to
Fisher’s exact test because mean health care cost for a
hospitalization (Mean of hospital stay days was 17.1 days)
on elderly people aged 70 years or older in 2010 was
¥502,708 JPY [24].
Results
Total health care costs between groups
The mean health care costs over the 2-year period were
slightly lower in the visit group (mean ± SEM
¥2,016,606 ± 161,432 JPY, approximately $20,166 ±
1,614 USD) than in the control group (¥2,287,450 ±
200,535 JPY, approximately $22,875 ± 2,005 USD), but
the difference was not significant (difference of 95 %
CI = -0.113 to 0.294; p = 0.38) when log-transformed
values were used for the t test.
The changes in total health care costs per month
throughout the study period between the two groups are
shown in Fig. 1. At most monthly time points, the costs in the
visit group were lower than those in the control group, and the
costs in the visit group were significantly lower than those in
the control group at 3 months (difference of 95 % CI =
0.017–0.489; p = 0.03), 11 months (0.102–0.566; 0.005),
12 months (0.003–0.434; 0.046), 13 months (0.051–0.542;
0.01), and 17 months (0.0004–0.534; 0.049) as determined
using log-transformed values according to the t test.
Health care costs for outpatient clinic utilization
between groups
In the visit group, the mean per-person health care cost for
outpatient clinic utilization over the 2-year period was
¥1,337,246 ± 102,913 JPY (approximately $13,372 ±
1,029 USD), which was lower than the mean cost in the
control group (¥1,637,667 ± 148,826 JPY, approximately
$16,377 ± 1,488 USD). However, this difference did not
quite reach statistical significance (difference of 95 %
CI = -0.003 to 0.355; p = 0.053) when log-transformed
values were used.
The per-person changes in the monthly health care costs
of outpatient clinic utilization are shown in Fig. 2. These
costs were lower in the visit group than in the control group
at all monthly time points, and the costs in the visit group
were significantly lower than the costs in the control group
at 1 month (difference of 95 % CI = 0.065–0.493;
p = 0.01), 6 months (0.057–0.455; 0.01), 7 months
(0.008–0.377; 0.04), 8 months (0.075–0.492; 0.008),
11 months (0.034–0.448; 0.02), 12 months (0.034–0.409;
0.02), 21 months (0.055–0.501; 0.01), and 23 months
(0.001–0.435; 0.048) as determined using log-transformed
values according to the t test.
Fig. 1 Monthly total health care costs of the groups during the study
period (the visit group N = 154; the control group N = 153).
(a) Numbers are raw data. (b) The yearly TTS average for 2008
was 1 USD = 104.5 JPY; this average for 2009 was 1 USD = 94.6
JPY. (c) A t test showed significant differences of each health care
cost between groups using log-transformed values at 3M (p = 0.03),
11M (p = 0.005), 12M (p = 0.046), 13M (p = 0.01) and 17M (p =
0.049)
Fig. 2 Monthly health care costs for outpatient clinic utilization of
the groups during the study period (the visit group N = 154; the
control group N = 153). (a) Numbers are raw data. (b) The yearly
TTS average for 2008 was 1 USD = 104.5 JPY; this average for 2009
was 1 USD = 94.6 JPY. (c) A t test showed significant differences of
each health care cost between groups using log-transformed values at
1M (p = 0.01), 6M (p = 0.01), 7M (p = 0.04), 8M (p = 0.008), 11M
(p = 0.02), 12M (p = 0.02), 21M (p = 0.01) and 23M (p = 0.048)
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Hospital care costs per person per month
between groups
The mean hospital care costs over the 2-year period in both
groups were almost same, mean visit group cost was
¥679,359 ± 119,827 JPY (approximately $6,794USD),
and mean control group cost ¥639,484 ± 124,511 JPY
(approximately $6,395 USD) This difference was not sig-
nificant (difference of 95 % CI = -0.036 to 0.355;
p = 0.49) using log-transformed values for the t test.
The distribution of monthly hospital care costs between
the groups is shown in Fig. 3. The number of participants
who were hospitalized per month ranged from 5 to 15 in
the visit group and from 5 to 14 in the control group.
Over the 2-year study period, the more costly hospital-
izations, which were defined as those costing more than the
mean of ¥500,000 JPY (approximately $5,000 USD) per
person per month, occurred significantly more often
(OR = 0.63; 95 % CI = 0.46–0.84; p = 0.002) in the
control group (N = 113) than in the visit group (N = 71).
Discussion
Total health care costs over the study period were not
significantly different between groups; but at most monthly
time points, total costs and those for outpatient clinic uti-
lization were lower in the visit group than those in the
control group. Moreover, hospitalizations that cost more
than ¥500,000 JPY per month were less likely to occur
among participants in the home visit group than among
participants in the control group.
The present analysis has shown that the preventive home
visit program, which consists of structured multidimen-
sional assessments and recommendations from community
health nurses and care managers, may reduce monthly
health care costs for ambulatory frail elderly individuals
who are certified as needing long-term care services, par-
ticularly avoiding costly hospitalizations.
We previously reported that the current preventive
home visit program facilitates the earlier use of public
long-term care services among ambulatory frail elderly
individuals [22]. These findings are similar to those of
another report [14] that found lower hospital and insti-
tutionalization costs but higher home care and adult day
care costs associated with a preventive home visit pro-
gram. Our interpretation of these results is that the rec-
ommendations of home visitors increased the focus on the
use of long-term care services [22], which tends to pre-
vent costly hospitalizations. Community health nurses or
care managers who visited the study participants were
likely able to assess the risks of serious health conditions
and provide preventive recommendations, including the
use of long-term care services. The use of long-term care
services, especially home-based long-term care services,
may be effective in preventing serious health conditions
because long-term service providers can detect health
changes early.
Fig. 3 Distribution of monthly hospital care costs of the groups
during the study period (N = 307). (a) The yearly TTS average for
2008 was 1 USD = 104.5 JPY; this average for 2009 was 1 USD =
94.6 JPY. (b) The number of participants who were hospitalized in
the visit group were ordered from 1 to 24 months; N = 14, 13, 6, 10,
15, 14, 15, 11, 11, 7, 5, 7, 8, 9, 10, 11, 10, 8, 7, 9, 10, 13, 11, 13.
(c) The number of participants who were hospitalized in the control
group were ordered from 1 to 24 months; N = 6, 10, 9, 9, 14, 7, 10, 5,
9, 10, 11, 9, 10, 13, 9, 11, 14, 9, 6, 9, 10, 10, 6, 10. (d) Hospitalizations
that accounted for more than 500,000 JPY: the visit vs. control group
(N = 71 vs. N = 113); OR = 0.63, p = 0.002
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Moreover, the long-term care costs over the study per-
iod, which were ¥378,010 JPY (approximately $3,780
USD) in the visit group and ¥273,231 JPY (approximately
$2,732 USD) in the control group [22], only amounted to
approximately 10 % of the total health care costs over the
same 2-year period (visit group: ¥2,016,606 JPY, approx-
imately $20,166 USD; control group: ¥2,287,450 JPY,
approximately $22,875 USD). Since remaining indepen-
dent in the home is valuable for older people, even if it
requires the use of in-home long-term care services, cost-
containment approaches should focus on reducing the total
health care costs that are incurred by illness or disability
(e.g., through the preventive home visit approach) rather
than simply reducing the long-term care costs alone.
The Statistical Bureau of the Japanese Ministry of
Internal Affairs and Communication reported that the
average annual per-person health care expenditures for the
Japanese population aged 75 years and older were
¥865,146 JPY (approximately $8,651 USD) in 2008 and
¥882,118 JPY (approximately $8,821 USD) in 2009 [25].
Thus, the total national average health care expenditure
over our 2-year study period for each Japanese elder
(2008–2009) was approximately ¥1,747,264 JPY (approx-
imately $17,472 USD). This amount is lower than the
expenditures for both groups in our analysis (visit group:
¥2,016,606 JPY, approximately $20,166 USD; control
group: 2,287,450 JPY, approximately $22,875 USD),
which is consistent with our study participants being frailer
and older and requiring more medical care than the general
elderly population. In Japan, the 2009 life expectancy at
birth was 83 years [26], which is the longest life expec-
tancy in the world; in 2009, health care expenditures
comprised 9.5 % of the nation’s gross domestic product,
which is lower than that in many other countries [26], and
the Japanese health care system seems to work well [27].
However, as mentioned previously [15], the proportion of
elders in the Japanese population will soon reach more than
40 %, and the number of frail elderly individuals is
increasing. These changes are associated with rising health
care expenditures for the types of frail elderly people who
comprised our study population, which creates a major
concern with regard to health care financing [28].
Even though health care costs and those for outpatient
clinic utilization in the visit group were lower than those in
the control group at most monthly time points of the per-
iod, the differences in total health care costs, those for
outpatient clinic utilization or those for hospitalization over
the period were not statistically significant between groups.
This is likely because preventive home visit programs do
not show their full effects immediately.
There are several limitations in the present study. First
of all, a limitation of the present study is that we did not
have detailed data regarding the exact medical diagnoses
and treatments that were reimbursed by health care insur-
ance programs in the outpatient clinics or hospitals for the
study participants. In particular, we were unable to evaluate
the processes of care or the reasons why the number of
costly hospitalizations was reduced in the visit group rel-
ative to the control group. Moreover, the average hospital
stay in Japanese elders aged 65 years or older is 44 days
[29]. However, some of hospitalizations may have been
counted as less than ¥500,000 JPY in the present study,
though they were part of consecutive hospitalizations that
actually cost more than ¥500,000 JPY.
Second, we were unable to analyze the costs for the
small number of participants who had employee-based
health insurance or public assistance. The number of older
individuals in Japanese metropolitan areas who depend on
public assistance is currently increasing [17], and they tend
to consume a disproportionate amount of medical resources
[30] even though they do not represent the majority of the
elderly population.
Third, our statistical analysis for testing differences of
health care costs at each monthly time point may have
overestimated statistical significance due to multiple
comparisons. In the future, a more rigorous and detailed
statistical analysis should be conducted for examining
health care costs of preventive home visits.
A further limitation of our study is that our preventive
home visit program is currently adapted to a local gov-
ernment population-based approach rather than a primary
care system. Further preventive home visit programs
should be tested using elderly medical checkup data
assessments or primary care physician assessments.
Conclusions
The present second analysis of randomized controlled trial
showed that a preventive home visit program can reduce
health care costs, primarily from reduced hospitalizations,
in addition to providing other major benefits. Further
research should be directed toward investigating health
care process during preventive home visit. Moreover, we
need to develop preventive home visit programs that link
better to primary care for ambulatory frail elders living at
home.
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